The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
AGICAP
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Acces GIR
Login
Català
Castellano
English
The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
AGICAP
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Search
Most popular
COL·LABORA
Menu
English
Català
Español
Home
Àrees Recerca
DIABETES
DAP_CAT
DAP_CAT
Grup de Recerca Epidemiològica en Diabetis des de l´Atenció Primària (DAP_CAT)
Group leader
Josep Franch Nadal
josep.franch@gmail.com
Presentation
Team
Publications
Projects
News
Presentation
Team
Publications
Projects
News
Projects
Group projects
Global and country-specific rates and trends in the incidence of diagnosed type 2 diabetes (GLOBALDIAB)
Principal investigators:
José Manuel Mata Cases
Code:
4R22/320
Start year:
2022
Funders:
Institut d’Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol)
Characteristics and cardiovascular and mortality outcomes in patients with type 2 diabetes mellitus initiating treatment with sodium-glucose cotransporter- 2 inhibitors and other diabetic medications
Principal investigators:
Josep Franch Nadal
Code:
9F17/004
Start year:
2017
Funders:
AstraZeneca Farmacéutica Spain, S.A.
Feasibility Assessment for Drug Utilization Study in European Country Databases
Principal investigators:
Josep Franch Nadal
Code:
9F20/003
Start year:
2020
Funders:
Janssen Research & Development, LLC
ContRol de la diabEteS tipo 2 En tIempoS de pandemia COVID-19 en centros de aTención primaria. Estudio RESIST
Principal investigators:
Bogdan Vlacho Vlacho, Josep Franch Nadal
Code:
4R21/096
Start year:
2021
Funders:
Redgedaps, s.l.
Evolución de la enfermedad renal en las personas con DM2 según los valores iniciales de filtrado glomerular y el tratamiento antidiabético. Estudio epiERDM2.cat
Principal investigators:
Joan-Antoni Vallès Callol
Code:
4R22/202
Start year:
2023
Funders:
Instituto de Salud Carlos III
Anterior
1
…
7
8
9
10
11
12
Següent
Board of Trustees
Collaborators
Accreditations